Concepedia

Muhammad Zubair Afzal

MZ

8

Publications

443

Citations

8

H-Index

2018

Active since

Affiliations

Dartmouth–Hitchcock Medical Center(Current)

USC Norris Comprehensive Cancer Center

Cotton (United States)

GTx (United States)

Muhammad Zubair Afzal is an author at Dartmouth–Hitchcock Medical Center specializing in cancer cell biology, immunology, and medicine.

ORCID

Top concepts

Publications per year

2018–2021

8

Publications

8

Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma

Muhammad Zubair Afzal, Rima R. Mercado, Keisuke Shirai · Journal for ImmunoTherapy of Cancer · 2018 · 164 citations · Full text

Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Receiving Concurrent Metformin and Immune Checkpoint Inhibitors

Muhammad Zubair Afzal, Konstantin H. Dragnev, Tayyaba Sarwar et al. · Lung Cancer Management · 2019 · 83 citations · Full text

Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study

Hongtao Duan, Tianhu Wang, Zhilin Luo et al. · Translational Lung Cancer Research · 2021 · 53 citations · Full text

Immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy alone versus immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy in combination with anti-RANKL denosumuab in malignant melanoma: a retrospective analysis at a tertiary care center

Muhammad Zubair Afzal, Keisuke Shirai · Melanoma Research · 2018 · 39 citations

Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone

Muhammad Zubair Afzal, Rodwell Mabaera, Keisuke Shirai · Journal for ImmunoTherapy of Cancer · 2018 · 34 citations · Full text

Rows per page

1–5 of 8